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Abstract
Retinoblastoma (Rb), the most common pediatric intraocular neoplasm, results from inacti-
vation of both alleles of the RB1 tumor suppressor gene. The second allele is most com-
monly lost, as demonstrated by loss of heterozygosity studies. RB1 germline carriers
usually develop bilateral tumors, but some Rb families display low penetrance and variable
expressivity. In order to decipher the underlying mechanisms, 23 unrelated low penetrance
pedigrees segregating the common c.1981C>T/p.Arg661Trp mutation and other low pene-
trance mutations were studied. In families segregating the c.1981C>T mutation, we dem-
onstrated, for the first time, a correlation between the gender of the transmitting carrier and
penetrance, as evidenced by Fisher’s exact test: the probability of being unaffected is
90.3% and 32.5% when the mutation is inherited from the mother and the father, respec-
tively (p-value = 7.10−7). Interestingly, a similar correlation was observed in families
segregating other low penetrance alleles. Consequently, we investigated the putative
involvement of an imprinted, modifier gene in low penetrance Rb. We first ruled out a
MED4-driven mechanism byMED4methylation and expression analyses. We then
focused on the differentially methylated CpG85 island located in intron 2 of RB1 and show-
ing parent-of-origin-specific DNA methylation. This differential methylation promotes
expression of the maternal c.1981C>T allele. We propose that the maternally inherited
c.1981C>T/p.Arg661Trp allele retains sufficient tumor suppressor activity to prevent reti-
noblastoma development. In contrast, when the mutation is paternally transmitted, the low
residual activity would mimic a null mutation and subsequently lead to retinoblastoma. This
implies that the c.1981C>T mutation is not deleterious per se but needs to be destabilized
in order to reach pRb haploinsufficiency and initiate tumorigenesis. We suggest that this
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phenomenon might be a general mechanism to explain phenotypic differences in low pen-
etrance Rb families.
Author Summary
Complex genotype-phenotype correlations lead to clinically and emotionally difficult situ-
ations. Improved understanding of these correlations is of utmost importance in medical
genetics. Low penetrance retinoblastoma families segregating the c.1981C>T / p.
Arg661Trp mutation are a good model as germline carriers develop bilateral, unilateral
retinoblastoma, benign retinomas or remain unaffected. The c.1981C>T mutation results
in a mutant pRb protein that is partially inactivated which may explain the reduced sever-
ity observed. However it is still unclear why this would be the case in some family mem-
bers and not in others. We have demonstrated a parent-of -origin effect in c.1981C>T / p.
Arg661Trp pedigrees and have concluded that overexpressed maternally inherited p.
Arg661Trp alleles retain sufficient tumor suppressor activity to prevent Rb development.
This might be a general phenomenon driving low penetrance retinoblastoma. Our findings
shed light on genotype-phenotype correlations in low penetrance retinoblastoma and are
of special relevance for genetic counselling.
Introduction
Retinoblastoma (Rb) is the most common pediatric intraocular neoplasm and occurs in 1 of
every 15,000 births. It results from the biallelic inactivation of the RB1 tumor suppressor gene,
located on 13q14 [1]. RB1 encodes the nuclear phosphoprotein pRB, which plays a prominent
role during the G1/S phase transition[2].
In tumors, both RB1 alleles can be inactivated via diverse mechanisms including point
mutations, large rearrangements, promoter hypermethylation and, most frequently, loss of the
second allele demonstrated by loss of heterozygosity studies. In non-hereditary retinoblastoma,
both RB1mutations are somatic and occur in the same retinal cell that develops into a tumor.
In contrast, in hereditary retinoblastoma, germline mutation of one allele is associated with
predisposition to Rb, while the second mutation on the other allele is somatic, usually acquired
during early childhood. Non-hereditary retinoblastomas are usually unilateral (one eye
affected) with a median age at diagnosis of 2 years, whereas hereditary cases are usually bilat-
eral (both eyes affected) with a median age at diagnosis of 1 year and an increased risk for sec-
ond tumors.
Familial hereditary Rb is defined as two or more carriers of an RB1 germline gene mutation
in a family and represents 10% of all retinoblastomas. Predisposition to Rb is transmitted as an
autosomal dominant trait with almost complete penetrance (over 90%) and germline carriers
usually develop bilateral or multifocal tumors. However, some Rb families display low pene-
trance (unaffected carriers) and variable expressivity (carriers develop bilateral, unilateral Rb
or even benign retinomas). Deciphering the mechanisms underlying low penetrance (LP) Rb is
of utmost importance, as it will impact the clinical management of these families and furthers
our understanding of Rb as a disease.
The well-known c.1981C>T / p.Arg661Trp low penetrance mutation in exon 20 of RB1
results in a mutant pRb that is partially inactivated [3,4] which may explain the reduced severity
observed. However, why this would be the case in some family members and not in others
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remains unclear. Based on the collection of large families, we have demonstrated, that in the
context of c.1981C>T/p.Arg661Trp low penetrance, a parent-of-origin effect impacts on Rb
phenotype. When the mutation is inherited from the paternal side, offspring are retinoblas-
toma-prone. In contrast, when the mutation is inherited from the maternal side, offspring
mostly remain unaffected. Based on these observations, the involvement of a putative modifier,
imprinted gene should be considered. Two alternative hypotheses were tested. Firstly, we
searched for a possible involvement of theMED4 gene, located in the flanking centromeric
region of RB1, as we have recently demonstrated thatMED4 expression is required for Rb devel-
opment [5]. We postulated maternal imprinting forMED4, which results in monoallelic expres-
sion from the paternal allele. As a result, when the RB1 c.1981C>T/p.Arg661Trp mutation is
inherited from the mother, loss of the contralateral paternal allele in the tumor would switch off
MED4 expression and prevent retinoblastoma development in the context of a low penetrance
mutation. Secondly, we focused on a differentially methylated CpG island showing parent-of-
origin-specific DNAmethylation at the RB1 gene and located in RB1 intron 2 (called CpG85
hereafter) [6,7]. Differential methylation of CpG85 skews RB1 expression in favor of the mater-
nal allele [6]. Our results on a series of germline, tumor DNAs and RNAs did not support any
involvement ofMED4 in the low penetrance phenotype, but confirmed the differentially meth-
ylated status of RB1 CpG85. It was therefore concluded that overexpressed maternally inherited
p.Arg661Trp alleles retain sufficient tumor suppressor activity to prevent Rb development. On
the other hand, when the mutation is paternally transmitted, the low residual activity would
mimic a null mutation, leading to haploinsufficiency and Rb development.
Results
Description of the families
We reviewed the records of 49 pedigrees from Institut Curie with a family history of Rb.
Thirty-four of these families segregated high penetrance mutations and 15 families segregated
low penetrance mutations. Eight low penetrance families derived from the literature were also
found by PubMed search and were added to the study (Table 1). All first generation carriers
were excluded to avoid any bias in DER calculation (Disease Eye Ratio, see “Patients and Meth-
ods” section).
High penetrance families. Unilateral Rb and bilateral Rb were identified in 7 (3 males and
4 females) and 71 patients (34 males and 37 females), respectively. Mean DER was 1.94.
p.Arg661Trp low penetrance families. Six families were derived from Institut Curie and
4 families were derived from the literature, corresponding to 85 germline carriers: 49 males and
36 females. Unilateral Rb was identified in 21 patients (12 males and 9 females), bilateral Rb
was identified in 12 patients (9 males and 3 females) and retinoma was identified in 2 patients.
The remaining 50 carriers were unaffected. Mean DER was 0.60. One pedigree segregating the
c.1981C>T/p.Arg661Trp mutation is shown (Fig 1).
Other low penetrance families. We found 9 families from Institut Curie and 6 families
from the literature segregating a non- c.1981C>T/p.Arg661Trp low penetrance RB1mutation
(i.e. c.-193T>G, c.10A>T, c.19del, c.43_65dup, c.45_79dup, c.607+1G>T, c.862-10T>C,
c.1331A>G, c.1422-2A>G, c.1960G>A, c.1960G>C), corresponding to 127 carriers of a
germline mutation. Unilateral Rb and bilateral Rb were identified in 34 and 15 patients, respec-
tively, and 68 carriers were unaffected. Mean DER was 0.53
Statistical analysis
The parental origin of the c.1981C>T/p.Arg661Trp mutant allele was documented in 71 of the
85 carriers. In this series of 71 carriers, 31 and 40 received the mutant allele from their mother
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and father, respectively. Twenty-eight carriers who received the mutant allele from their
mother remained unaffected (28/31, 90.3%), and only 3 developed Rb (3/31, 9.7%). In contrast,
13 carriers who received the mutant allele from their father remained unaffected (13/40,
32.5%) and 27 developed Rb (27/40, 67.5%). Consequently, inheriting the c.1981C>T/p.
Arg661Trp mutation from the maternal side significantly prevented Rb development (p-
value = 7.10−7, Fisher’s exact test). In other words, the probability of being unaffected when the
Table 1. Description of low penetrance families. DER: disease-eye ratio (see text for details). Nomenclature follows HGVS rules using the reference
sequence NM_000321.2. Previously published families are indicated. Pedigrees F6, F7, F16, F17, F20-22 were from our series and have been published in
part (see text for details). Families F14 and F15 were removed from statistical analysis (see text for details).
Family Mutation description Expected consequence Number affected Total number of carriers DER Comments
F1[8] c.1981C>T p.Arg661Trp 5 6 1 4 Unilateral Rb
1 Bilateral Rb
F2[8] c.1981C>T p.Arg661Trp 3 5 0.6 3 Unilateral Rb
F3[9] c.1981C>T p.Arg661Trp 7 18 0.56 3 Bilateral Rb
4 Unilateral Rb
F4[10] c.1981C>T p.Arg661Trp 6 10 0.8 2 Bilateral Rb
2 Unilateral Rb
2 retinomas
F5 c.1981C>T p.Arg661Trp 2 11 0.18 2 Unilateral Rb
F6[11] c.1981C>T p.Arg661Trp 4 8 1 4 Bilateral Rb
F7[11] c.1981C>T p.Arg661Trp 5 18 0.33 4 Unilateral Rb
1 Bilateral Rb
F8 c.1981C>T p.Arg661Trp 1 2 0.5 1 Unilateral Rb
F9 c.1981C>T p.Arg661Trp 1 3 0.33 1 Unilateral Rb
F10 c.1981C>T p.Arg661Trp 1 3 0.67 1 Bilateral Rb
F11[12] c.1960G>C p.Val654Leu 7 16 0.44 7 Unilateral Rb
F12 c.1960G>A p.Val654Met 1 4 0.5 1 Bilateral Rb
F13 c.10A>T p.Lys4* 1 3 0.33 1 Unilateral Rb
F14[13] c.607+1G>T Exon 6 skipped 13 25 0.84 5 Unilateral Rb
8 Bilateral Rb
F15[13] c.607+1G>T Exon 6 skipped 3 10 0.4 2 Unilateral Rb
1 Bilateral Rb
F16[11] c.607+1G>T Exon 6 skipped 2 5 0.4 2 Unilateral Rb
F17[11] c.607+1G>T Exon 6 skipped 3 5 1 1 Unilateral Rb
2 Bilateral Rb
F18 c.1696-2A>G 2 4 0.5 2 Unilateral Rb
F19[14] c.1331A>G Exon 13 skipped 2 8 0.25 2 Unilateral Rb
F20[11] c.45_79dup p.Pro27Leufs*50 1 6 0.17 1 Unilateral Rb
F21[11] c.1422-2A>G Exon 16 skipped 3 4 1 2 Unilateral Rb
1 Bilateral Rb
F22[11] c.-193T>G Promoter 2 3 1 1 Unilateral Rb
1 Bilateral Rb
F23 c.19del p.Arg7Glufs*58 1 5 0.2 1 Unilateral Rb
F24[15] c.43_65dup p.Pro23Leufs*50 4 10 0.4 3 Unilateral Rb
1 retinoma
F25[16] c.862-10T>C Exon 9 skipped 4 9 0.55 3 Unilateral Rb
1 Bilateral Rb
doi:10.1371/journal.pgen.1005888.t001
A Parent-of-Origin Effect Impacts Rb Phenotype
PLOS Genetics | DOI:10.1371/journal.pgen.1005888 February 29, 2016 4 / 14
mutation is inherited from the maternal side is 90.3% versus only 32.5% when the mutation is
inherited from the paternal side.
We then looked for a similar disequilibrium in families segregating non-p.Arg661Trp low
penetrance mutant alleles (see Table 1). To avoid any bias, families F14 and F15 segregating
Fig 1. Family F7 segregating the RB1 c.1981C>T/p.Arg661Trp mutation.Genotype is provided for tested members as m/n for heterozygous carriers and
n/n for homozygous wild-type. OC indicates obligate carriers. Blackened symbols: bilateral Rb; half-blackened symbols: unilateral Rb; dotted symbols:
unaffected carriers; dashed symbols: deceased.
doi:10.1371/journal.pgen.1005888.g001
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the c.607+1 G>T mutation were excluded from analysis since a parent of origin effect was pre-
viously described [13]. The parental origin of the mutant alleles was documented in 58 of the
82 remaining carriers. Seventeen carriers received the mutation from their mother and 41
received the mutation from their father. Thirteen carriers who received the mutant allele from
their mother were unaffected (13/17, 76.4%) and 4 developed Rb (4/17, 23.6%). Eighteen carri-
ers who received the mutation from their father were unaffected (18/41, 43.9%) and 23 devel-
oped Rb (23/41, 56.1%). Fisher’s exact test demonstrated a disequilibrium between the gender
of the transmitting carrier parent and penetrance (p-value = 0.041). Lastly, families segregating
high penetrance mutations displayed no such correlation, as all 54 mutation carriers of known
parental origin developed retinoblastoma, regardless of the gender of the transmitting carrier.
As previously described, no preferential transmission of mutant or normal alleles from carrier
fathers or mothers was observed [17]. These results unambiguously demonstrate that, in the
context of low penetrance Rb, a parent-of-origin effect impacts on Rb phenotype.
RB1CpG85 methylation analyses
Blood samples. To determine whether RB1 CpG85 is differentially methylated in a par-
ent-of-origin-specific manner, we studied the methylation pattern of 9 CpG dinucleotides
within the CpG85 island using bisulfite treatment and pyrosequencing in DNAs extracted
from blood. For all non-deleted RB1 samples (i.e. with 2 RB1 alleles), the C-to-T ratio at the
CpG dinucleotides studied was close to 1:1, indicating 50% methylation at CpG85 (S1A Fig).
We then studied 6 Rb patients with a large RB1 deletion of known parental origin. All 3
patients with loss of the maternal RB1 allele showed absence of methylation at CpG85 (S1B
Fig). In contrast, CpG85 was fully methylated in all 3 patients with loss of the paternal RB1
allele (S1C Fig). These results confirmed that RB1 is imprinted and that CpG85 is specifically
methylated on the maternal allele.
Tumor samples. To assess a putative imprinting defect at CpG85, the methylation level of
3 CpG islands within RB1 was analysed in 2 normal retinas and 45 tumors. CpG106 is located
in the promoter region, while CpG85 and CpG42 are located in intron 2. In normal retina
DNAs, CpG106 was hypomethylated, while a high DNAmethylation level was observed for
CpG42 (Fig 2A). CpG85 displayed approximately 50% methylation (Fig 2A), in agreement
with genomic imprinting at this locus. Interestingly, CpG85 was fully methylated in all but 3
tumor DNA samples (Fig 2B). These results strongly suggest, for the first time, loss of imprint-
ing at CpG85 locus in retinoblastoma.
RB1 allelic imbalance. To assess specific expression imbalance of RB1 according to the
sex of the transmitting parent, a quantitative SNaPshot assay targeting the c.1981C>T/p.
Arg661Trp mutation was used within a series of 20 carriers including the low penetrance fam-
ily F5. To avoid any bias due to a putative exon skipping, exon 20 inclusion was first confirmed
by a dedicated RNA study (S2 Fig). Next, using the mutated allele as a marker, we found allelic
imbalance in favour of the maternal allele in all 20 patients, albeit to different extend (Table 2
and Fig 3). Surprisingly, in family F5, unaffected carriers 1, 4, 5, 6 and 8 showed higher expres-
sion of the mutant allele whereas affected probands 3 and 7 showed higher expression of the
wild type allele. Allelic ratio was close to equilibrium for the unaffected carrier 2 and in favour
of the mutant allele for the unaffected carrier 9. A similar expression pattern was found in the
other c.1981C>T carriers as all affected individuals showed a lower expression of the mutant
allele (Table 2). These results confirmed the higher expression of the maternally transmitted
RB1 allele but raised questions about genotype-phenotype correlation as higher expression of
the mutant allele and lack of penetrance appeared to be linked.
A Parent-of-Origin Effect Impacts Rb Phenotype
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MED4 analyses. To determine whetherMED4 CpG53 is differentially methylated in a par-
ent-of-origin-specific manner, we used bisulfite treatment and pyrosequencing on 24 DNA
samples extracted from blood. CpG53 from all 24 samples showed fully unmethylated pattern.
Similarly, the 45 tumor DNAs and normal retina analyzed by bisulfite treatment and methyla-
tion array were found to be unmethylated at the CpG53 locus (S3 Fig). These results excluded a
parent-of-origin regulation ofMED4 viaMED4 promoter differential methylation.
To assess whetherMED4 is imbalanced in a parent-of-origin manner, we looked for mono-
allelic expression using theMED4 rs41284209 SNP as a marker. We identified 9 patients who
were heterozygous carriers of the rs41284209 SNP. No significant allelic disequilibrium was
detected by Sanger sequencing and SNaPhot analyses (S4 and S5 Figs). Overall these results
showed that both parental alleles contributed equally toMED4 expression and ruled outMED4
parental imprinting.
Discussion
Deciphering the molecular basis of low penetrance retinoblastoma is of utmost importance for
both researchers and clinicians, as it will shed light on retinoblastoma development, allow
prognostic assessment in low penetrance families, and promote optimal genetic counseling and
ophthalmological surveillance. In this study, we have identified, for the first time, a parent-of-
origin effect in families segregating the c.1981C>T/p.Arg661Trp mutation. In these families,
the probabilities of being unaffected for germline carriers were 90.3% and 32.5% when the
mutation was inherited from the maternal and paternal side, respectively. Interestingly, a
Fig 2. Methylation analyses ofRB1 CpG islands usingmethylation array. X axis represents the position on chromosome 13. Y axis represents overall
methylation level. CpG106 localizing in RB1 promoter is shown in green, CpG42 is shown in pink and CpG85 is shown in blue. For each sample, multiple
CpGs are located within an island and each dot represents a single result. A: Normal retina. CpG85 showing approximately 50% of methylation. B: Tumor
sample. CpG85 displaying a hypermethylated profile.
doi:10.1371/journal.pgen.1005888.g002
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similar correlation was observed in families segregating other low penetrance alleles, albeit to a
lesser extent: probabilities of being unaffected were 76.5% and 43.9% when the mutation was
inherited from the maternal and paternal side, respectively. This finding echoes the maternal
protective effect previously described in 2 families (F14 and F15 in this paper) in association
with the c.607+1G>T low penetrance mutation [13]. Restoration of the maternal truncated
transcript or mutation at an imprinted locus in cis were proposed to explain this observation.
Our own results on a large number of pedigrees segregating a distinct low penetrance mutation
rule out the first hypothesis, but support the second hypothesis.
We have recently shown that retinoblastoma RB1 -/- cells cannot survive in the absence of
MED4, both in vitro and in orthotopic xenograft models in vivo, therefore identifyingMED4 as
a survival gene in retinoblastoma [5]. Consequently, we considered aMED4-driven general
mechanism to explain low penetrance retinoblastoma. We postulated a parent-of-origin regu-
lation ofMED4 that would be able to skewMED4 expression in favor of the maternal allele. As
a result, when the p.Arg661Trp mutation is inherited from the mother, loss of the contralateral
paternal allele would dramatically decreaseMED4 expression and prevent retinoblastoma
development in the context of a low penetrance mutation. However, methylation and expres-
sion studies both ruled out this mechanism to explain the parent-of-origin effect observed in p.
Arg661Trp pedigrees.
A recent study demonstrated RB1 imprinting by a differentially-methylated-region (DMR)
at CpG85 in RB1 intron 2. In humans, this DMR is methylated on the maternal allele and
remains unmethylated on the paternal allele. Consequently, CpG85 acts as a weak promoter
for an alternative, paternally expressed, RB1 transcript (RB1-E2B) that competes with the main
RB1 transcript. This transcriptional interference skews RB1 expression in favor of the maternal
allele [6,18].
Table 2. Expression imbalance in 20 carriers of the c.1981C>T/p.Arg661Trp mutation. Transmission in family F5 is detailed Fig 3. First degree relatives
are indicated for the other families. See text for ratio calculation. (*) See Fig 3.
Family Patient Carrier status Parental origin of the c.1981C>T allele Ratio c.1981C>T /WT
F5 1 Unaffected Maternal* 1.48
F5 2 Unaffected Paternal* 0.95
F5 3 Unilateral Paternal* 0.39
F5 4 Unaffected Maternal* 1.85
F5 5 Unaffected Maternal* 1.45
F5 6 Unaffected Maternal* 1.86
F5 7 Unilateral Paternal* 0.21
F5 8 Unaffected Maternal* 1.25
F5 6 Unaffected Paternal* 0.71
F6 1 Bilateral Paternal 0.69
F6 2 Unaffected Paternal 0.46
F6 3 Bilateral Paternal (son of F6-2) 0.40
F7 1 Unaffected Maternal 2.27
F7 2 Unilateral Paternal 0.69
F7 3 Bilateral Paternal 0.62
F8 1 Unilateral First generation carrier 0.38
F8 2 Unaffected Maternal (daughter of F8-1) 1.43
F9 1 Unaffected First generation carrier 0.50
F9 2 Unilateral Paternal (daughter of F9-1) 0.85
F9 3 Unaffected Paternal (daughter of F9-1) 0.91
doi:10.1371/journal.pgen.1005888.t002
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In line with this previous report, our SNAPshot analyses targeting the c.1981C>T/p.
Arg661Trp mutation demonstrated higher expression of the maternal RB1 allele. Our results
also demonstrated that, when this mutation is inherited from the maternal side, offspring
mostly remain unaffected. Although counter-intuitive, this means that a high level of the
c.1981C>T/p.Arg661Trp mutant allele would protect from retinoblastoma. A plausible expla-
nation lies in the residual biochemical properties of p.Arg661Trp mutants, which lack E2F
pocket protein-binding activity but retain E2F-independent tumor suppressor function and
the wild-type ability to partially suppress colony growth of RB(-) cells and induce parameters
of cell differentiation [19]. More broadly, an E2F-independent paradigm of tumor suppression
is being developed for RB1[20]. Lastly, a study showed that certain LP alleles (p.Arg661Trp
included) retain greater functional activity than expected, which is why additional cooperating
events are needed to block this residual activity [21]. The competing RB1-E2B transcript that
lowers RB1 regular transcript on the paternal allele might constitute this additional event in
low penetrance Rb families. Consequently, when the father transmits the mutation, the residual
pRb activity is too low to prevent the development of Rb in the cell. The low residual activity
Fig 3. RB1 allelic imbalance in family F5. The normalized SNaPshot cDNA ratio between the mutant and the wild type alleles are indicated below each
carrier individual with corresponding SNaPshot results. The c.1981C>T/p.Arg661Trp mutant allele “T” is indicated in green and the wild type allele “C” is
indicated in blue. Dotted symbols: unaffected carriers; half-blackened symbols: unilateral Rb.
doi:10.1371/journal.pgen.1005888.g003
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would mimic a null mutation, leading to genomic instability and Rb development. This also
means that the c.1981C>T/p.Arg661Trp mutation is not deleterious per se but needs to be
destabilized in order to reach pRb haploinsufficiency and initiate genomic instability and
tumorigenesis [22,23]. Although our results on low penetrance families segregating other LP
alleles reached borderline significance (p = 0.041), we propose this hypothesis as a general
mechanism to explain disease occurrence in the context of low penetrance Rb.
Intriguingly, we have also reported, for the first time, a hypermethylated, deregulated RB1
imprint in Rb tumors. Hypermethylation of CpG85 inhibits RB1-E2B transcription, therefore
enhancing RB1main transcript expression. A plausible explanation would be that this loss of
imprinting at the CpG85 locus might be used by tumor cells to attempt to increase the expres-
sion of pRB and thus restore its tumor suppressor activity.
Overall, we demonstrated that a parent-of-origin effect is involved in low penetrance Rb
families segregating the c.1981C>T/p.Arg661Trp mutation of RB1 and propose this phenome-
non as a general mechanism to explain phenotypic differences in low penetrance Rb families.
Materials and Methods
Ethics statement
All patients have given written informed consent during genetic counselling sessions. The
study was approved by the Groupe Thématique Transverse (GTT) “retinoblastome” of Institut
Curie medical center (2013–2310).
Patients
Institut Curie is the national referral center for retinoblastoma in France. Diagnosis of Rb is
established on the basis of examinations by an ophthalmologist and histopathological criteria
when treatment involves enucleation. All Rb patients are offered genetic counseling and RB1
gene mutation analysis in constitutional and tumor DNA. When a germline mutation is found,
molecular testing is extended to relatives. Individual written consent for genetic analysis was
obtained from all participating patients or their legal guardians. The study was approved by
our local ethic committee and retinoblastoma board.
In our series of 1,210 consecutively ascertained cases, we surveyed 49 pedigrees with a family
history of Rb. Seven of the low penetrance families have been previously published in part[11].
We included family members for which the mutational status was ascertained by RB1 analysis
and obligate carriers when a DNA sample was not available. Relatives underwent routine fun-
dus examination to look for the presence of retinomas (retinal scars). Since it has been
described that retinoma develops after homozygous loss of RB1[24], individuals with retinoma
were considered to be affected. Obligate carriers with normal fundus examination were consid-
ered to be non-penetrant or unaffected. Mutational mosaicism is known to explain the variable
expressivity and penetrance in Rb patients[25]. Consequently, we excluded all first-generation
carriers of a germline mutation displaying unilateral Rb or remaining unaffected, since retinal
mosaicism could not be excluded in these patients. Clinical features included disease status
(affected / unaffected) and diseased-eye ratio (DER). The DER is defined as the ratio of the
sum of the eyes affected by tumors to the number of mutation carriers in a family. It provides a
useful combination of penetrance and expressivity. Families with a DER 1.5 are considered
to display complete penetrance. Families with a DER 1 are designated as LP[8].
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Statistical analysis
Fisher’s exact test was performed using R statistical software v3.0.2 on i) 10 p.Arg661Trp fami-
lies (6 from our series and 4 from the literature [8,9,10]), ii) 13 non-p.Arg661Trp low pene-
trance families (9 from our series and 4 from the literature [11,12,14,15,16], iii) 34 high
penetrance families from our series.
RB1CpG85 andMED4 CpG53 methylation analyses
Blood samples and pyrosequencing. Blood DNAs from 17 Rb patients (including 2 carriers
of the p.Arg661Trp mutation and 6 carriers of a large deletion of known parental origin) and 2
controls underwent bisulfite conversion using the EZ DNAMethylation-Gold kit (Zymo
research) according to the manufacturer’s instructions. Pyrosequencing primers were designed to
cover the whole CpG85 island using the PyroMark Assay Design Software v1.0.6 (Qiagen). Bisul-
fite conversion was assessed by PCR amplification using converted DNA specific primers and
agarose gel electrophoresis. Samples were prepared with the PyroMark Q96 VacuumWorksta-
tion and pyrosequencing was performed on a PyroMark Q96 (Qiagen) according to the manufac-
turer’s instructions with subsequent analysis using the Analysis software package v2.5.7 (Qiagen).
Tumor samples and CGHmethylation analyses. Tumor DNAs from 45 Rb patients (6
bilaterally and 39 unilaterally affected cases, respectively) and DNA samples from 2 normal ret-
ina were collected and hybridized on Infinium HumanMethylation 450 BeadChip arrays (Illu-
mina, San Diego, CA). Prior to hybridization, DNA samples underwent bisulfite conversion
using the EZ DNAMethylation Kit (Zymo Research). Four microliters of bisulfite-converted
DNA were used for hybridization, following the Illumina Infinium HDMethylation protocol.
Data were normalized using GenomeStudio (Illumina, Inc.) and R statistical software v3.0.2.
Expression analyses
RNA extraction and RT PCR. Total RNAs were extracted from 200 μL frozen stabilized
blood samples with the Nucleospin RNA Blood kit (Macherey-Nagel), according to the manu-
facturer’s instructions. Nagel). RNA quality was controlled using the NanoDrop 1000 Spectro-
photometer (Thermo Scientific). Reverse transcription (RT) was performed with random
hexamers using the RNA PCR core kit GeneAmp (Applied Biosystems) according to the man-
ufacturer’s instructions.
Allelic imbalance at the rs41284209MED4 SNP. To assess a putativeMED4 expression
imbalance, cDNAs from 9 patients heterozygous for the rs41284209MED4 SNP were analyzed
by Sanger sequencing and SNaPshot assay.
In order to avoid contamination by genomic DNA, we amplified a large cDNA fragment
(3658 bp) containing the rs41284209MED4 SNP and spanning exons 6 to the 3’UTR. Targeted
sequencing was then performed using the BigDye Terminator Cycle Sequencing V1.1 Ready
Reaction kit (Applied Biosystems) and following electrophoresis in an ABI 3500 Genetic Ana-
lyzer (Applied Biosystems). Sequence analyses were performed using Alamut version 2.4
(Interactive Biosoftware, Rouen, France) and FinchTV version 1.4.0 (Geospiza, Inc) softwares.
The SNaPshot assay was performed as described below.
Allelic imbalance at the c.1981C>T RB1mutation. Quantitative SNaPshot assay was
performed using primers targeting the c.1981C>T RB1mutation and the SNaPshot quantita-
tive primer extension assay (Applied Biosystems), following a previously detailed protocol[26].
Briefly, to determine whether our assay was able to quantitatively measure allelic imbalance,
tumor DNA homozygous for the p.Arg661Trp mutation and wild type DNA were mixed at
the following ratios (100:0, 80:20, 60:40, 50:50, 40:60, 20:80 and 0:100), then SNaPshot was suc-
cessfully tested. The peak ratios were measured between the two allelic versions that is, c.1981C
A Parent-of-Origin Effect Impacts Rb Phenotype
PLOS Genetics | DOI:10.1371/journal.pgen.1005888 February 29, 2016 11 / 14
to c.1981T/p.Arg661Trp. cDNA ratios were then normalized with respect to the values
obtained on genomic DNA (cDNA ratios/gDNA ratios) to correct from putative variations in
dye incorporation induced by the nucleotide sequence (see S1 Table for an example). All exper-
iments were performed in duplicate.
Supporting Information
S1 Table. Allelic imbalance within a subset of patients from family F5.
(DOC)
S1 Fig. RB1 CpG85 methylation analysis by pyrosequencing in blood samples. The sequence
to analyzed is indicated at the top of each pyrogram; Y represents the 9 cytosine residues
studied that were either methylated or unmethylated. Bisulfite treatment of DNA converts
unmethylated cytosine residues to uracil, whereas 5-methylcytosine residues remain
unchanged. Bisulfite-treated DNA sequences will then display a thymine or a cytosine at each
CG dinucleotide depending on the methylation status of the cytosine. X axis represents the
order of sequential dispensing of enzyme (E), substrate (S) and nucleotides [adenine (A), thy-
mine (T), cytosine (C) and guanine (G)]. Y axis represents peak intensity, which is propor-
tional to the number of dispensed nucleotides incorporated in the sequence. The CG
dinucleotides analyzed are shaded on pyrograms. The percentage indicated in colored squares
above the corresponding peaks represents the proportion of remaining cytosine residues at the
corresponding CG dinucleotide, which in turn indicates the level of methylation at the CG site.
The color of the squares above the corresponding peak reflects quality assessment. Yellow rep-
resents high quality and blue represents intermediate quality. A. Affected RB1 p.Arg661Trp
carrier displaying approximately 50% CpG85 methylation. B. Patient with a large deletion of
maternal RB1 allele showing no methylation at CpG85. C: Patient with a large deletion of
paternal RB1 allele showing fully methylated CpG85.
(DOC)
S2 Fig. Exon 20 RNA analysis. Exon 20 contains the c.1981 C>T mutation. Exon 19/exon 20
junction is indicated at the top of the electrophoregrams. The c.1981C>T mutation is indicated
by an arrow. Panel A: without puromycin. Panel B: with puromycin. Non sense mediated
decay inhibition by puromycin didn’t reveal any out of frame defect. Targeted RNA analysis
showed exon 20 inclusion and absence of skipping.
(TIF)
S3 Fig. Methylation analyses ofMED4 CpG53 using methylation array. X axis represents
the position on chromosome 13. Y axis represents overall methylation level. SUCLA2 and
NUDT15 are neighboring genes.MED4 CpG53 is represented in green. A: Normal retina.
CpG53 is unmethylated. B: Tumor sample. CpG53 is unmethylated.
(TIF)
S4 Fig.MED4 expression analysis in lymphocytes analyzed by SNaPshot assay. TheMED4
rs41284209 SNP (c.783A>G) was used for allelic discrimination. Panel A, genomic results,
panel B, cDNA results. No allelic disequilibrium was found.
(TIF)
S5 Fig.MED4 expression analysis in lymphocytes analyzed by Sanger sequencing. The
MED4 rs41284209 SNP (c.783A>G) was used for allelic discrimination. Electropherograms
of 4 heterozygous carriers displayed no allelic disequilibrium on forward (A) and reverse (B)
strands.
(TIF)
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